Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology
Tommaso Angelone, Carmine Rocca, Vincenzo Lionetti, et al.
Antioxidants and Redox Signaling (2024) Vol. 40, Iss. 7-9, pp. 369-432
Closed Access | Times Cited: 18
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca
Vascular Pharmacology (2025), pp. 107462-107462
Closed Access | Times Cited: 1
Mitochondrial quality control: Biochemical mechanism of cardiovascular disease
Francesca Inferrera, Ylenia Marino, Tiziana Genovese, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025) Vol. 1872, Iss. 3, pp. 119906-119906
Closed Access | Times Cited: 1
Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction
Michael W. Rudokas, Margaret McKay, Zeren Toksoy, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Obesity and Cancer Rehabilitation for Functional Recovery and Quality of Life in Breast Cancer Survivors: A Comprehensive Review
Lorenzo Lippi, Alessandro de Sire, Arianna Folli, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 521-521
Open Access | Times Cited: 5
Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects
Zhen‐Yu Chen, Zhiyin Li, Ruilong Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6749-6768
Closed Access | Times Cited: 5
Integrative analysis of genes provides insights into the molecular and immune characteristics of mitochondria-related genes in atherosclerosis
Zhipeng Zheng, Huimin Lu, Xiaowen Wang, et al.
Genomics (2025) Vol. 117, Iss. 2, pp. 111013-111013
Open Access
Role and Mechanism of Mitochondrial Ribosomal Proteins in Septic Myocardial Injury
Longfei Wu, Junchao Huang, Xiongfei Jia, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2677-2698
Open Access
Ca2+ Signaling in Cardiac Fibroblasts: An Emerging Signaling Pathway Driving Fibrotic Remodeling in Cardiac Disorders
Francesco Moccia, Antonio Totaro, Germano Guerra, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 734-734
Open Access
High-fidelity spatio-temporal recognition of mitochondrial esterase with an on-demand photoactivation strategy
Lixin Sun, Huili Liu, Zehua Qian, et al.
Science China Chemistry (2025)
Closed Access
Mitophagy in Alzheimer's disease and other metabolic disorders: a focus on mitochondrial-targeted therapeutics
Shadt Skawratananond, Daniel X Xiong, Charlie Zhang, et al.
Ageing Research Reviews (2025), pp. 102732-102732
Closed Access
TP53INP2 promotes mitophagic degradation of YAP to impede dedifferentiated liposarcoma development
Yixuan Wang, Ying Huang, Liwei Wang, et al.
Oncogene (2025)
Closed Access
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma
Honghao Zhang, Hao Wang, Yuxing Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216802-216802
Closed Access | Times Cited: 4
Investigating the temporal link between PM2.5 exposure and acceleration of myocardial ischemia reperfusion injury: Emphasizing the hazardous presence of metals in inhaled air
Bhavana Sivakumar, Gino A. Kurian
Environmental Pollution (2024) Vol. 355, pp. 124113-124113
Closed Access | Times Cited: 4
Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?
Petra Kleinbongard, Ioanna Andreadou
Current Heart Failure Reports (2024) Vol. 21, Iss. 4, pp. 292-304
Open Access | Times Cited: 3
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure
Anna De Bartolo, Teresa Pasqua, Naomi Romeo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells
Teresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Cell Proliferation (2024) Vol. 57, Iss. 12
Open Access | Times Cited: 2
A Review of Advances in Mitochondrial Research in Cancer
Zhiru Li, Wu Zhang, Shaowei Guo, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Mechanisms of Myocardial Edema Development in CVD Pathophysiology
Diana G. Kiseleva, Tatiana V. Kirichenko, Yuliya V. Markina, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 465-465
Open Access | Times Cited: 1
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations
Antonio Curcio, Roberta Rocca, Federica Chiera, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1427-1427
Open Access | Times Cited: 1
A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of FcγRIIA receptor
Anna De Bartolo, Naomi Romeo, Alessandro Marrone, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus
Haitao Wang, Rui Tang, Qiuwei Pan, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113722-113722
Closed Access | Times Cited: 1
Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell
Ioannis Paraskevaidis, Christos Kourek, Dimitrios Farmakis, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1534-1534
Open Access | Times Cited: 1
Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: any place for drug repurposing?
Elisa Avolio, Barbara Bassani, Marzia Campanile, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100033-100033
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top